163 related articles for article (PubMed ID: 27028131)
21. Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
Lenherr SM; Clemens JQ; Braffett BH; Dunn RL; Cleary PA; Kim C; Herman WH; Hotaling JM; Jacobson AM; Brown JS; Wessells H; Sarma AV;
Diabet Med; 2016 Nov; 33(11):1528-1535. PubMed ID: 27028025
[TBL] [Abstract][Full Text] [Related]
22. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M
Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643
[TBL] [Abstract][Full Text] [Related]
23. Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
Rahimi K; Otto CM
Heart; 2017 Nov; 103(21):1653-1655. PubMed ID: 29025920
[No Abstract] [Full Text] [Related]
24. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
[TBL] [Abstract][Full Text] [Related]
25. Haptoglobin phenotype and vascular complications in patients with diabetes.
Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
[No Abstract] [Full Text] [Related]
26. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.
Möllsten A; Jorsal A; Lajer M; Vionnet N; Tarnow L
Diabetologia; 2009 Dec; 52(12):2590-3. PubMed ID: 19834686
[TBL] [Abstract][Full Text] [Related]
27. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
[TBL] [Abstract][Full Text] [Related]
28. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.
Nusca A; Tuccinardi D; Proscia C; Melfi R; Manfrini S; Nicolucci A; Ceriello A; Pozzilli P; Ussia GP; Grigioni F; Di Sciascio G
Cardiovasc Diabetol; 2019 Nov; 18(1):147. PubMed ID: 31706305
[TBL] [Abstract][Full Text] [Related]
29. Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes.
Ji H; Godsland I; Oliver NS; Hill NE
PLoS One; 2020; 15(6):e0234319. PubMed ID: 32542057
[TBL] [Abstract][Full Text] [Related]
30. Haptoglobin phenotype and diabetic nephropathy.
Nakhoul FM; Zoabi R; Kanter Y; Zoabi M; Skorecki K; Hochberg I; Leibu R; Miller B; Levy AP
Diabetologia; 2001 May; 44(5):602-4. PubMed ID: 11380078
[TBL] [Abstract][Full Text] [Related]
31. [Revascularization of coronary artery disease in diabetes mellitus].
Wexberg P; Weidinger F
Wien Med Wochenschr; 2010 Jan; 160(1-2):40-3. PubMed ID: 20229160
[TBL] [Abstract][Full Text] [Related]
32. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
[TBL] [Abstract][Full Text] [Related]
33. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
[TBL] [Abstract][Full Text] [Related]
34. [Glycaemic control and macrovascular complications in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2007 Jan; 148(1):17-20. PubMed ID: 17344113
[TBL] [Abstract][Full Text] [Related]
35. Haptoglobin phenotype and coronary artery collaterals in diabetic patients.
Hochberg I; Roguin A; Nikolsky E; Chanderashekhar PV; Cohen S; Levy AP
Atherosclerosis; 2002 Apr; 161(2):441-6. PubMed ID: 11888529
[TBL] [Abstract][Full Text] [Related]
36. Long term risk of severe retinopathy in childhood-onset type 1 diabetes: a data linkage study.
White M; Sabin MA; Magnussen CG; O'Connell MA; Colman PG; Cameron F
Med J Aust; 2017 May; 206(9):398-401. PubMed ID: 28490305
[TBL] [Abstract][Full Text] [Related]
37. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
[TBL] [Abstract][Full Text] [Related]
38. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
Maddaloni E; Coleman RL; Agbaje O; Buzzetti R; Holman RR
Lancet Diabetes Endocrinol; 2020 Mar; 8(3):206-215. PubMed ID: 32032540
[TBL] [Abstract][Full Text] [Related]
39. The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes.
Kretowski A; Hokanson JE; McFann K; Kinney GL; Snell-Bergeon JK; Maahs DM; Wadwa RP; Eckel RH; Ogden LG; Garg SK; Li J; Cheng S; Erlich HA; Rewers M
Diabetologia; 2006 Aug; 49(8):1946-54. PubMed ID: 16770585
[TBL] [Abstract][Full Text] [Related]
40. Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Orchard TJ; Backlund JC; Costacou T; Cleary P; Lopes-Virella M; Levy AP; Lachin JM;
J Diabetes Complications; 2016; 30(8):1577-1584. PubMed ID: 27539884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
